CN Patent
CN111995541B — 含有稳定重同位素的酰胺官能团的化合物及其应用
Assigned to Junshi Runjia Shanghai Pharmaceutical Technology Co ltd · Expires 2025-05-06 · 1y expired
What this patent protects
本发明提供了式(I)所示的含稳定重同位素富集的酰胺官能团的化合物,其用于调整药物或前药的药代动力学特性、代谢特性和/或递送效率,以及其治疗和预防效果。本发明还涉及含同位素富集的酰胺的药物和前药在治疗或预防疾病病症和症状中的应用。
USPTO Abstract
本发明提供了式(I)所示的含稳定重同位素富集的酰胺官能团的化合物,其用于调整药物或前药的药代动力学特性、代谢特性和/或递送效率,以及其治疗和预防效果。本发明还涉及含同位素富集的酰胺的药物和前药在治疗或预防疾病病症和症状中的应用。
Drugs covered by this patent
- Itovebi (INAVOLISIB) · Genentech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.